CHK1 affects cell sensitivity to microtubule-targeted drugs

Related Experiment Video

Updated: Aug 22, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Qing Ren1, Ronghua Liu, Adam Dicker

  • 1Department of Radiation Oncology, Kimmel Cancer Center of Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Journal of Cellular Physiology
|September 25, 2004
PubMed

Insights

Checkpoint kinase 1 (CHK1) influences cell sensitivity to microtubule-targeted anticancer drugs. Higher CHK1 expression confers resistance to microtubule stabilizers like taxotere but sensitivity to destabilizers like nocodazole.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Pharmacology

Background:

  • Microtubules are crucial targets for numerous anticancer drugs.
  • Understanding cellular responses to these drugs is key to overcoming drug resistance and improving tumor control.
  • The role of CHK1 in modulating sensitivity to microtubule-targeting agents remains largely unexplored.

Purpose of the Study:

  • To investigate the novel role of CHK1 in cellular sensitivity to microtubule-targeted drugs.
  • To elucidate the relationship between CHK1 expression levels and responses to microtubule stabilizers and destabilizers.
  • To explore the potential of targeting CHK1 for enhancing cancer therapy.

Main Methods:

  • Utilized a pair of transformed rat fibroblast cell lines with differing CHK1 expression levels (A1-5 vs. B4).
  • Assessed cellular sensitivity to taxotere (microtubule stabilizer) and nocodazole (microtubule destabilizer).
  • Investigated microtubule formation and employed Chk1 siRNA to reverse observed effects.

Main Results:

  • A1-5 cells with higher CHK1 expression exhibited increased resistance to taxotere.
  • Conversely, A1-5 cells showed heightened sensitivity to nocodazole compared to B4 cells.
  • Altered drug sensitivities and reduced microtubule formation in A1-5 cells were reversible with Chk1 siRNA.
  • These findings link CHK1 to altered microtubule dynamics.

Conclusions:

  • CHK1 is a significant factor influencing cellular response to microtubule-targeted drugs.
  • CHK1 expression levels impact resistance to taxotere and sensitivity to nocodazole.
  • Targeting CHK1 may represent a viable strategy for sensitizing CHK1-overexpressing tumors to taxotere.

More Related Videos

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...